Page last updated: 2024-08-21

fluorobenzenes and Embolism, Pulmonary

fluorobenzenes has been researched along with Embolism, Pulmonary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Danielson, E; Fonseca, FA; Genest, J; Glynn, RJ; Gotto, AM; Kastelein, JJ; Koenig, W; Libby, P; Lorenzatti, AJ; MacFadyen, JG; Nordestgaard, BG; Ridker, PM; Shepherd, J; Willerson, JT	1

Trials

1 trial(s) available for fluorobenzenes and Embolism, Pulmonary

Article	Year
A randomized trial of rosuvastatin in the prevention of venous thromboembolism. The New England journal of medicine, 2009, Apr-30, Volume: 360, Issue:18 Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Fluorobenzenes; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Pulmonary Embolism; Pyrimidines; Risk; Rosuvastatin Calcium; Sulfonamides; Venous Thromboembolism; Venous Thrombosis	2009

Article

Year

A randomized trial of rosuvastatin in the prevention of venous thromboembolism.

The New England journal of medicine, 2009, Apr-30, Volume: 360, Issue:18

Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Female; Fluorobenzenes; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Pulmonary Embolism; Pyrimidines; Risk; Rosuvastatin Calcium; Sulfonamides; Venous Thromboembolism; Venous Thrombosis

2009